Ownership history in DEARBORN PARTNERS LLC · 52 quarters on record
This page tracks every 13F SEC filing in which DEARBORN PARTNERS LLC reported a position in AbbVie Inc COM (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 141,951 | -32,095 | -18.4% | 1.62% | $32.4M | $226.67 |
| 2025 Q3 | REDUCED | 174,046 | -479 | -0.3% | 1.89% | $40.3M | $228.05 |
| 2025 Q2 | ADDED | 174,525 | +2,265 | +1.3% | 1.53% | $32.4M | $181.25 |
| 2025 Q1 | REDUCED | 172,260 | -39,882 | -18.8% | 1.73% | $36.1M | $202.72 |
| 2024 Q4 | REDUCED | 212,142 | -2,265 | -1.1% | 1.58% | $37.7M | $170.33 |
| 2024 Q3 | REDUCED | 214,407 | -5,410 | -2.5% | 1.72% | $42.3M | $187.79 |
| 2024 Q2 | REDUCED | 219,817 | -2,055 | -0.9% | 1.63% | $37.7M | $161.62 |
| 2024 Q1 | REDUCED | 221,872 | -80,335 | -26.6% | 1.73% | $40.4M | $170.00 |
| 2023 Q4 | REDUCED | 302,207 | -6,443 | -2.1% | 1.71% | $46.8M | $143.30 |
| 2023 Q3 | ADDED | 308,650 | +188 | +0.1% | 1.81% | $46.0M | $136.47 |
As of 2025 Q4 — sorted by position size